Introduction: The objective of this study was to evaluate the clinical characteristics of patients with coexistence of diabetes and liver disease in the internal medicine department of Donka University Hospital. Diabetes is defined as chronic hyperglycemia resulting from genetic and environmental phenomena. Chronic liver disease is a disease of the liver that persists over a long period of time. According to the WHO, diabetes is one of the four non-communicable diseases targeted along with cardiovascular diseases, cancers and respiratory diseases. Viral infections, particularly hepatitis B and C, are common causes of liver disease, affecting approximately 325 million people worldwide. Methods: It was a study descriptive type prospective study lasting 15 months from March 1, 2023 to June 30, 2024. We have included all patients admitted for chronic liver disease on the grounds of known diabetes or incidental discovery whose age ≥ 18 years, regardless of gender, from any origin managed in the internal medicine department, with diagnostic criteria blood glucose ≥ 1.26 g/l [7 mmol/l] on two occasions after fasting for more than 8 hours, or venous blood glucose at any time of the day ≥ 2 g/l [11.1 mmol/l] with signs of hyperglycemia or blood glucose 2 hours after a glucose load (OGTT at 75 g of glucose) ≥ 2 g/l [11.1 mmol/l], HbAlc ≥ 6.5 after eliminating hemoglobinopathies and having given verbal consent. Results: Out of 809 hospitalized patients, 50 patients had liver disease associated with diabetes. The mean age of the patients was 54.7 years with extremes of 25 and 95 years. The male sex was predominant with a sex ratio of 1.24. Asthenia was the main sign of diabetes encountered and the main signs of liver disease were lower limb edema and jaundice. The main complication of diabetes was dominated by strokes (36%) and liver diseases: gastrointestinal bleeding and hepatic encephalopathy. Conclusion: The prevalence of the association of diabetes and liver disease was not negligible during our study. Emphasis should be placed on strengthening early detection of diabetes and liver disease and appropriate management.
References
[1]
Guariguata, L., Whiting, D., Weil, C. and Unwin, N. (2011) The International Diabetes Federation Diabetes Atlas Methodology for Estimating Global and National Prevalence of Diabetes in Adults. DiabetesResearchandClinicalPractice, 94, 322-332. https://doi.org/10.1016/j.diabres.2011.10.040
[2]
Zahm, V. (2020) Therapeutic Strategy in Type 2 Diabetes: Practical Survey on the Therapeutic Attitude of French General Practitioners in Relation to National Recommendations. Thesis of Medicine, University of Strasbourg.
[3]
International Diabetes Federation (2022) Diabetes Atlas 2022. 10th Edition, International Diabetes Federation.
[4]
Askenasy, E.M. and Askenasy, N. (2013) Is Autoimmune Diabetes Caused by Aberrant Immune Activity or Defective Suppression of Physiological Self-Reactivity? AutoimmunityReviews, 12, 633-637. https://doi.org/10.1016/j.autrev.2012.12.004
[5]
Antonelli, A., Ferrari, S.M., Giuggioli, D., Di Domenicantonio, A., Ilaria Ruffilli, I., Corrado, A., et al. (2014) Hepatitis C Virus Infection and Type 1 and Type 2 Diabetes Mellitus. WorldJournalofDiabetes, 5, 586-600. https://doi.org/10.4239/wjd.v5.i5.586
[6]
Jaafar, J., de Kalbermatten, B., Scheen, A.J. and Jornayvaz, F.R. (2014) Maladies hépatiques chroniques et diabète. RevueMédicaleSuisse, 10, 1254-1260. https://doi.org/10.53738/revmed.2014.10.433.1254
[7]
Latrech, H. and Baizri, H. (2009) Endocrinology Diabetology Nutrition. Elsevier Masson.
[8]
Baldé, N.M., Camara, A., Kouroum, K. and Kaké, A. (2007) Clinical Characteristics of Hepatitis B and HIV Seroprevalence in 248 Diabetics in Conakry, Guinea. BlackAfricanMedicine, 5403, 174-178.
[9]
Kabbaj, N., Errabih, I., Guédira, M., El Atmani, H., Benabed, K., Al Hamany, Z., etal. (2006) Hépatite virale C et diabète: Influence du diabète sur l’évolution de l’hépatopathie. Annalesd’Endocrinologie, 67, 233-237. https://doi.org/10.1016/s0003-4266(06)72591-4
[10]
Schillie, S.F., Xing, J., Murphy, T.V. and Hu, D.J. (2012) Prevalence of Hepatitis B Virus Infection among Persons with Diagnosed Diabetes in the United States, 1999-2010. Journal of Viral Hepatitis, 19, 674-676. http://www.ncbi.nlm.nih.gov/pubmed.
[11]
CDC (2012) Diabetes and Hepatitis B Vaccination. http://www.cdc.gov/diabetes/pubs/pdf/hepb_vaccination.pdf
[12]
Ameur, F.Z., Ben Amor, S., Ghannei, O., Ben Mansour, W., Ben Chaaben, N. and Safer, L. (2021) Prévalence du diabète type 2 chez les patients ayant une stéatose hépatique non alcoolique. Annalesd’Endocrinologie, 82, 506. https://doi.org/10.1016/j.ando.2021.08.742
[13]
Diarra, M.T., Konaté, A., Diakité, Y., Doumbia Samaké, K., Sow Coulibaly, H., Kassambra, Y., etal. (2013) Infection par le virus de l’hépatite C chez les patients diabétiques traités au CHU Gabriel Touré et au Centre de lutte contre le diabète de Bamako (Mali). JournalAfricaind’Hépato-Gastroentérologie, 7, 188-191. https://doi.org/10.1007/s12157-013-0487-7
[14]
Geist, C. (2013) Admission for Deterioration of “General Condition” to the Emergency Reception and Treatment Service (SAU) of the New Civil Hospital of Strasbourg. Urgences 2014, 1-9.
[15]
Ouavene, J.O., Koffi, B., Mobima, T., Bekondji, C., Massengue, A. and Guenebem, A.K. (2014) Liver Cirrhosis at the Bangui Friendship Hospital: Epidemiological, Clinical, Ultrasound Aspects and Diagnostic Problems. AfricanJournalofMedicalImaging, 5, 1-2.
[16]
Mahamane, S.M.A., Ada, A., Tchatath, N.N.V., Daou, M., Brah, S., Andia, A., etal. (2018) Particularities of Diabetes in Subjects Aged Over 60 Years in Niger. Health Sciences and Diseases, 19, 10-14.
[17]
Pais, R. (2017) Diabète, facteur d’aggravation des hépatopathies. MédecinedesMaladiesMétaboliques, 11, 687-691. https://doi.org/10.1016/s1957-2557(17)30164-5